ArticleOncotarget2024

Regorafenib synergizes with TAS102 against multiple gastrointestinal cancers and overcomes cancer stemness, trifluridine-induced angiogenesis, ERK1/2 and STAT3 signaling regardless of KRAS or BRAF mutational status.

Jun Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.